The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery
Brief Summary
Patients scheduled for primary hip replacement needs postoperative pain treatment, i.e. morphine. Morphine has side-effects: nausea, vomiting, sedation and dizziness. These side-effects are unpleasant for the patients and sometimes keeps them at bed longer time than needed. We investigate in new combinations of analgesics for postoperative pain, hoping to minimize the need for morphine.
Intervention / Treatment
-
Gabapentin + dexamethasone + ketamine (DRUG)Comparing analgesic effect of gabapentin 1200 mg + dexamethasone 8 mg + ketamine 0.15 mg/kg
-
Placebo (DRUG)Matching placebo
Condition or Disease
- Pain, Postoperative
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Terminated |
Study results: | No Results Available |
Age: | 55 Years to 85 Years |
Enrollment: | 48 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Treatment |
Masking |
Clinical Trial Dates
Start date: | Oct 01, 2005 | |
---|---|---|
Primary Completion: | Apr 01, 2008 | ACTUAL |
Completion Date: | May 01, 2008 | ACTUAL |
Study First Posted: | Oct 12, 2005 | ESTIMATED |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | May 14, 2008 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
The effect on postoperative pain of the combination of preoperative gabapentin 1200 mg + dexamethasone 8 mg + ketamine 0.15mg/kg versus placebo is investigated on patients having a hip alloplastic operation.
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 55 |
Maximum Age: | 85 |
Healthy Volunteers: | Yes |
Inclusion Criteria:
* Patients scheduled for primary total hip replacement,
* Between 55 and 85 years of age,
* ASA 1-3 and BMI between 18 and 35.
Exclusion Criteria:
Patients who are:
* Unable to cooperate
* Does not speak Danish
* Has allergy for drugs used in the trial
* Drug or alcohol abuse
* Epilepsy
* Medically treated diabetes
* Known kidney disease
* Daily use of analgetics
* Apart from NSAID
* Paracetamol or COX2 inhibitors
* Are treated with a antidepressive.
* Patients scheduled for primary total hip replacement,
* Between 55 and 85 years of age,
* ASA 1-3 and BMI between 18 and 35.
Exclusion Criteria:
Patients who are:
* Unable to cooperate
* Does not speak Danish
* Has allergy for drugs used in the trial
* Drug or alcohol abuse
* Epilepsy
* Medically treated diabetes
* Known kidney disease
* Daily use of analgetics
* Apart from NSAID
* Paracetamol or COX2 inhibitors
* Are treated with a antidepressive.
Primary Outcomes
-
The total amount of morphine needed postoperatively from 0-4h; and 0-24h, administered by a patient controlled pain treatment.(PCA) 0-24h
Secondary Outcomes
-
Pain score (VAS)= at rest and at mobilisation. 0-24h
-
Postoperative Nausea and vomiting. 0-24h
-
Dizziness 0-24h
-
Sedation 0-24h
-
Nightmare and hallucinations. 0-24h
-
All measurements are taken at 2,4 and 24 h postoperatively. 0-24h
More Details
NCT Number: | NCT00236223 |
---|---|
Other IDs: | SM2-05 |
Study URL: | https://clinicaltrials.gov/study/NCT00236223 |
Last updated: Sep 29, 2023